Newsroom

Inflammatix Moving Into Coronavirus Test Market With Gene Expression Host Response Platform

Oct 8, 2020

Machine Learning-Based Rapid Diagnostic Reads Immune System to Predict COVID-19 Severity Risk

Sep 30, 2020

Three Predictions For Healthcare Platforms

Sep 8, 2020

20 medical device startups you need to know

Jun 26, 2020

MedTech Innovator Announces Top 50 Medtech Startups Selected for Annual Showcase and Accelerator

Jun 22, 2020

The Battle for a Better Sepsis Test

Apr 1, 2020

Stanford alumni founders tackle COVID-19 with StartX task force

Mar 19, 2020

Leading Stanford Alumni Scientists and Physicians Launch StartX Med COVID-19 Task Force

Mar 18, 2020

Inflammatix named to Fierce 15 MedTech list

Mar 9, 2020

New Technologies Can Step Up Fight Against Antimicrobial Resistance and Sepsis

Jan 10, 2020

Inflammatix raises $32M, plus a BARDA contract, for its point-of-care infection diagnostics

Jan 10, 2020

Inflammatix Raises $32M in Series C Financing

Jan 10, 2020

Your medical devices are getting smarter. Can the FDA keep them safe?

Oct 9, 2023

Point-of-care testing for infectious diseases in emergency settings

Jan 18, 2023

Do Your Genes Know What’s Making You Sick?

Jan 6, 2022

Artificial Intelligence for Clinical Decision Support in Sepsis

May 13, 2021

Inflammatix Checks off All the Right Boxes with Investors

Mar 19, 2021

Inflammatix nets $102M to advance its immune system tests for infectious diseases

Mar 16, 2021

Infection-detection system from Peninsula company scores $102M, aims to hit market this year

Mar 16, 2021

A Bright Future Ahead for Novel Markers of Infection

Dec 15, 2020

Inflammatix Awarded $7.4M in Additional BARDA Funding for POC System, Acute Infection Test

Oct 29, 2020